Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
US Army
Farmers Insurance
QuintilesIMS
Boehringer Ingelheim

Generated: August 25, 2019

DrugPatentWatch Database Preview

Litigation Details for Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc. (D. Del. 2015)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc. (D. Del. 2015)

Docket   Try a Free Trial Date Filed 2015-08-31
Court District Court, D. Delaware Date Terminated 2017-11-09
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Sherry R. Fallon
Parties GILEAD SCIENCES IRELAND UC; GILEAD SCIENCES, INC.; JANSSEN PHARMACEUTICA, N.V.; JANSSEN SCIENCES IRELAND UC; MYLAN INC.; MYLAN PHARMACEUTICALS, INC.
Patents 7,125,879; 8,080,551; 8,101,629; 8,841,310
Attorneys Andrew Colin Mayo; Brian E. Farnan; Brian H. Pandya; Colleen Tracy James; Gregory L. Diskant; Irena Royzman; Jacob Siegel; James H. Wallace , Jr.; James Michael Lennon; Jordan M. Engelhardt; Lachlan Campbell-Verduyn; Manuel J. Velez; Mark A. Pacella; Michael J. Farnan; Pilar Gabrielle Kraman; Ryan M. Mott; Scott A. McMurry; Steven J. Balick; Susan E. Morrison; Tiffany Geyer Lydon; Wesley E. Weeks
Firms Devlin Law Firm LLC; Farnan LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial , and   Try a Free Trial .

Details for Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-08-31 1 by Mylan of U.S. Patent Nos. 8,841,310 B2 ("the '310 Patent"), 7,125,879 B2 ("the &… '879 Patent") and 8,101,629 B2 ("the '629 Patent") (collectively, "the Patents-in-suit… Patents-in-suit") arising under the patent laws of the United States, 35 U.S.C. ยงยง 1 et seq. This…United States Patent and Trademark Office ("the PTO") issued the '310 Patent, entitled "…#39;310 Patent. 29. On October 24, 2006, the PTO issued the '879 Patent, entitled External link to document
2017-01-06 201 construction for a disputed term in U.S. Patent No. 8,101,629. Within five days the parties shall submit…PageID #: 5500 Plaintiffs own U.S. Patent 8,101,629 claiming the invention of a pharmaceutical…Plaintiffs filed this patent infringement suit. (D.I. 1). The '629 patent is one of eight asserted…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2017-11-09 258 United States Patent Nos. 8,841,310 (the '310 patent), 7,125,879 (the '879 patent), 8, 101,629… the '310 patent, the '879 patent, the '629 patent, the '551 patent, the '856… (the '629 patent), 8,080,551 (the '551 patent), 7,399,856 (the '856 patent), 7,563,922…the '922 patent), 8, 101, 752 (the '752 patent) and 8,618,291 (the '291 patent) (collectively…856 patent and the '922 patent. 5. Mylan and its officers, directors, employees, agents External link to document
2017-11-15 259 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,841,310 B2; 7,125,879 B2; 8,101,629…2015 9 November 2017 1:15-cv-00760 830 Patent None District Court, D. Delaware External link to document
2016-01-26 34 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,841,310 B2; 7,125,879 B2; 8,101,629…2015 9 November 2017 1:15-cv-00760 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Argus Health
Medtronic
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.